Genor Biopharma-B (02595.HK): Repurchased a total of 872,000 H shares as of September 18

Zhitong Finance APP News, GenFleet Therapeutics-B (02595.HK) announced that as of September 18, 2026, the Company conducted a series of H share repurchases on The Stock Exchange of Hong Kong Limited, repurchasing a total of 872,000 H shares, accounting for approximately 0.227% of the Company's total issued share capital as of the date of this announcement. The Company may assess market conditions and continue to implement its 2026 H share repurchase plan.